TAHL CINDY
SEC CIK 1655472 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | See Remarks | 589.4K | — | $13.15M | 26 | 2021-07-01 | 2026-08-04 |
Most active insiders at FATE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Valamehr Bahram | Pres, CEO, Dir | — | $168.1K |
| 2 | TAHL CINDY | See Remarks | — | $154.7K |
| 3 | Adawi Kamal | CFO | — | — |
| 4 | Redmile Group, LLC | Dir, 10% | — | — |
| 5 | EPSTEIN ROBERT S | Dir | — | — |
| 6 | RASTETTER WILLIAM H | Dir | — | — |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 16:03 | 2026-08-04 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | S - Sale | $2.46 | -38.8K | 589.4K | -6% | -$95.4K | |
| 2026-05-21 16:02 | 2026-05-20 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | S - Sale | $1.88 | -25.6K | 628.2K | -4% | -$48.1K | |
| DM | 2026-05-07 16:00 | 2026-05-06 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | M - OptEx | $1.25 | +166.7K | 653.7K | +34% | +$208.0K |
| D | 2026-01-16 | 2026-01-15 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | A - Grant | $0.00 | +100.0K | 487.1K | +26% | $0 |
| 2026-01-12 | 2026-01-09 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | S - Sale | $1.06 | -10.6K | 387.1K | -3% | -$11.2K | |
| 2025-08-05 | 2025-08-04 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | S - Sale | $1.06 | -9,037 | 397.7K | -2% | -$9,579 | |
| D | 2025-01-16 | 2025-01-15 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | A - Grant | $0.00 | +70.0K | 406.7K | +21% | $0 |
| 2025-01-13 | 2025-01-10 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | S - Sale | $1.55 | -5,654 | 336.7K | -2% | -$8,764 | |
| 2024-07-31 | 2024-07-29 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | A - Grant | $0.00 | +200.0K | 342.4K | +140% | $0 | |
| 2024-01-10 | 2024-01-09 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale | $4.37 | -10.9K | 142.4K | -7% | -$47.5K | |
| 2023-11-13 | 2023-11-09 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale | $2.40 | -24.4K | 153.2K | -14% | -$58.5K | |
| 2023-01-11 | 2023-01-10 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale | $5.24 | -11.6K | 177.6K | -6% | -$60.5K | |
| D | 2022-06-02 | 2022-06-01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale+OE | $22.96 | -25.0K | 189.2K | -12% | -$574.0K |
| D | 2022-06-02 | 2022-06-01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | M - OptEx | $6.55 | +25.0K | 214.2K | +13% | +$163.8K |
| DM | 2022-04-04 | 2022-04-01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | M - OptEx | $5.22 | +25.0K | 214.2K | +13% | +$130.5K |
| D | 2022-04-04 | 2022-04-01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale+OE | $38.85 | -25.0K | 189.2K | -12% | -$971.2K |
| D | 2022-01-27 | 2022-01-25 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | A - Grant | $0.00 | +33.3K | 189.2K | +21% | $0 |
| M | 2022-01-13 | 2022-01-11 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale | $48.53 | -5,419 | 155.8K | -3% | -$263.0K |
| M | 2022-01-12 | 2022-01-10 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale | $46.43 | -7,738 | 161.9K | -5% | -$359.3K |
| DM | 2022-01-04 | 2022-01-03 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale+OE | $59.34 | -50.0K | 214.6K | -19% | -$2.97M |
| D | 2022-01-04 | 2022-01-03 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | M - OptEx | $6.55 | +50.0K | 219.0K | +30% | +$327.5K |
| 2021-11-22 | 2021-11-19 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | A - Grant | $0.00 | +61.0K | 169.0K | +56% | $0 | |
| DM | 2021-10-04 | 2021-10-01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale+OE | $58.83 | -50.0K | 141.7K | -26% | -$2.94M |
| D | 2021-10-04 | 2021-10-01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | M - OptEx | $6.55 | +50.0K | 158.0K | +46% | +$327.5K |
| DM | 2021-07-02 | 2021-07-01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | S - Sale+OE | $85.24 | -55.5K | 160.8K | -26% | -$4.73M |
| DM | 2021-07-02 | 2021-07-01 | FATE | FATE THERAPEUTICS INC | TAHL CINDY | GC, Sec | M - OptEx | $5.64 | +55.5K | 163.6K | +51% | +$313.2K |
Purchase Sale Sale after option exercise All abbreviations